MatsukiyoCocokara & Co. (TYO:3088)
Japan
· Delayed Price · Currency is JPY 2,333.50
-9.00 (-0.38%)
Feb 21, 2025, 3:30 PM JST
MatsukiyoCocokara & Co. Revenue
MatsukiyoCocokara & Co. had revenue of 275.79B JPY in the quarter ending December 31, 2024, with 5.04% growth. This brings the company's revenue in the last twelve months to 1.05T, up 4.61% year-over-year. In the fiscal year ending March 31, 2024, MatsukiyoCocokara & Co. had annual revenue of 1.02T with 7.49% growth.
Revenue (ttm)
1,053.72B
Revenue Growth
+4.61%
P/S Ratio
0.91
Revenue / Employee
78.81M
Employees
13,371
Market Cap
941.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,022.53B | 71.28B | 7.49% |
| Mar 31, 2023 | 951.25B | 221.28B | 30.31% |
| Mar 31, 2022 | 729.97B | 173.06B | 31.08% |
| Mar 31, 2021 | 556.91B | -33.69B | -5.70% |
| Mar 31, 2020 | 590.59B | 14.60B | 2.54% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |